
Sign up to save your podcasts
Or


Rahul Banerjee, MD, FACP discusses the state of the art treatment in Multiple Myeloma Care at the 2024 ASH Annual Meeting.
Video: https://medicaldigest.org/scientific-contents/interview:bridging-gaps-multiple-myeloma-care-community-oncologists-guide-navigating-evolving-treatment-landscape
Matthew S. Davids, MD, MMSc discusses the state of the art treatment in chronic lymphocytic leukemia at the 2024 ASH Annual Meeting.
Video: https://medicaldigest.org/scientific-contents/interview:crafting-custom-care-cll-guidance-upfront-and-sequential-treatment-decisions-targeted-and-immune-base-platforms
Anand A. Patel, MD discusses the state of the art treatment in adult acute lymphoblastic leukemia at the 2024 ASH Annual Meeting.
Video: https://medicaldigest.org/scientific-contents/interview:state-art-treatment-adult-all
Catherine S. Diefenbach, MD discusses the state of the art treatment in lymphoma care at the 2024 ASH Annual Meeting.
Video: https://medicaldigest.org/scientific-contents/interview:state-art-treatment-lymphoma
Prof. Francesco Passamonti discusses the state of the art treatment in myelofibrosis Care at the 2024 ASH Annual Meeting.
Video: https://medicaldigest.org/scientific-contents/interview:mastering-art-myelofibrosis-care-expert-guidance-clinical-experience-innovation-more-personalized-disease-control
Kerry A Rogers, MD discusses current questions and controversies in the management of chronic lymphocytic leukemia at the 2024 ASH Annual Meeting.
Video: https://medicaldigest.org/scientific-contents/interview:addressing-current-questions-and-controversies-management-chronic-lymphocytic-leukemia
Michael J. Mauro, MD discusses current questions and controversies in the management of chronic myeloid leukemia at the 2024 ASH Annual Meeting.
Video: https://medicaldigest.org/scientific-contents/interview:addressing-current-questions-and-controversies-management-chronic-myeloid-leukemia
Mikkael A. Sekeres, MD, MS discusses the state of the art treatment in MDS at the 2024 ASH Annual Meeting.
Video: https://medicaldigest.org/scientific-contents/interview:state-art-treatment-myelodysplastic-syndromes
Prof. Gilles Salles presented a 5-year analysis of the POLARIX study at the 2024 ASH Annual Meeting.
Video: https://medicaldigest.org/scientific-contents/interview:five-year-analysis-polarix-study
Prof. Gilles Salles discusses managing first relapse in diffuse large B-Cell lymphoma outside of CAR-Ts at the 2024 ASH Annual Meeting.
Video: https://medicaldigest.org/scientific-contents/interview:managing-first-relapse-diffuse-large-b-cell-lymphoma-outside-car-ts
From the publisher's feed

319 Listeners